Literature DB >> 14735305

Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae.

Arne Warth1, Stephan Kröger, Hartwig Wolburg.   

Abstract

Vasogenic edema is one of the most serious clinical problems in brain tumors and tightly connected to water shifts between the different fluid compartments in the brain. Aquaporin water channels have been recognized to have an important impact on the development of edematous swelling in the brain. Astrocytes, which are believed to induce or at least maintain the blood-brain barrier in the brain capillary endothelial cells, express the aquaporin isoform AQP4. Normally, AQP4 is highly concentrated in the glial membrane where astrocytes contact mesenchymal space, such as perivascular or brain superficial regions. Parenchymal membranes do not show any immunocytochemical AQP4-specific signal. We investigated the AQP4 expression in human glioblastoma and correlated it with the expression pattern of the extracellular heparan sulfate proteoglycan agrin and members of the dystrophin-dystroglycan complex. We found that AQP4 completely covered the surface of the glioma cells. alpha-Dystroglycan was absent from glial membranes but retained in endothelial membranes. Utrophin and dystrophin remained restricted to the endfoot membrane in those cells in which AQP4 had been redistributed, whereas alpha-syntrophin redistributed together with AQP4 across the entire cell surface. Since alpha-dystroglycan operates as a binding protein for agrin, these observations support the suggestions that (1) AQP4 is tightly associated with the dystrophin-dystroglycan complex, and (2) agrin is necessary for the polarized distribution of AQP4 in the astrocyte. The results are discussed in connection with the fact that normally AQP4 is assembled in the so-called orthogonal arrays of particles (OAPs). The restriction of AQP4/OAPs to the endfoot membrane may be dependent on the presence of agrin, and this might be essentially connected to the ability of astrocytes to maintain the integrity of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735305     DOI: 10.1007/s00401-003-0812-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  61 in total

1.  Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.

Authors:  Ying-Liang Liu; Zhi-Ming Xu; Guo-Yuan Yang; Dian-Xu Yang; Jun Ding; Hao Chen; Fang Yuan; Heng-Li Tian
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

Review 2.  Therapeutic strategies to improve drug delivery across the blood-brain barrier.

Authors:  Tej D Azad; James Pan; Ian D Connolly; Austin Remington; Christy M Wilson; Gerald A Grant
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

Review 3.  Cell-cell signaling in the neurovascular unit.

Authors:  Josephine Lok; Punkaj Gupta; Shuzhen Guo; Woo Jean Kim; Michael J Whalen; Klaus van Leyen; Eng H Lo
Journal:  Neurochem Res       Date:  2007-04-25       Impact factor: 3.996

Review 4.  Aquaporins in the brain: from aqueduct to "multi-duct".

Authors:  Jérôme Badaut; Jean-François Brunet; Luca Regli
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy.

Authors:  Eain M Cornford; Shigeyo Hyman
Journal:  NeuroRx       Date:  2005-01

Review 6.  Aquaporin-4 in hepatic encephalopathy.

Authors:  K V Rama Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

7.  Reduced migration of Ishikawa cells associated with downregulation of aquaporin-5.

Authors:  Xiu Xiu Jiang; Kai Hong Xu; Jun Yan Ma; Yong Hong Tian; Xiao Yan Guo; Jun Lin; Rui Jin Wu
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

8.  Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.

Authors:  Xing-Long Gu; Cai-Xia Long; Lixin Sun; Chengsong Xie; Xian Lin; Huaibin Cai
Journal:  Mol Brain       Date:  2010-04-21       Impact factor: 4.041

9.  Aquaporin and vascular diseases.

Authors:  Carla Loreto; Ester Reggio
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

10.  Aquaporins and glia.

Authors:  Roberta Albertini; Rossella Bianchi
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.